Tyers Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Tyers Asset Management’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$199K	Buy	7,238 +264	+4%	+$7.82K	0.01%	715
2019 Q2	$231K	Hold	6,974	–	–	0.01%	696
2019 Q1	$244K	Hold	6,974	–	–	0.01%	662
2018 Q4	$232K	Hold	6,974	–	–	0.01%	636
2018 Q3	$351K	Buy	6,974 +1,276	+22%	+$63K	0.01%	592
2018 Q2	$341K	Hold	5,698	–	–	0.01%	531
2018 Q1	$261K	Buy	5,698 +242	+4%	+$10.1K	0.01%	600
2017 Q4	$217K	Buy	5,456 +1,144	+27%	+$45.2K	0.01%	662
2017 Q3	$172K	Buy	4,312 +572	+15%	+$24.8K	0.01%	686
2017 Q2	$161K	Buy	3,740 +1,760	+89%	+$62.6K	0.01%	662
2017 Q1	$62K	Buy	1,980 +198	+11%	+$5.31K	﹤0.01%	783
2016 Q4	$45K	Buy	+1,782	New	+$39.8K	﹤0.01%	808

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

ACM

Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return

Tyers Asset Management's SUPN Position: Q3 2019 in Review

Tyers Asset Management increased its Supernus Pharmaceuticals (SUPN) stake by 3.8% in Q3 2019, buying an estimated $7.82K and bringing the position to 7,238 shares worth $199K. The position accounts for 0.01% of the portfolio, ranked #715.

Tyers Asset Management first reported a position in SUPN in Q4 2016 and has held it in 12 quarters since. The position peaked at $351K in Q3 2018. 243 funds tracked by Wall St. Rank hold SUPN as of Q3 2019.

Tyers Asset Management held 7,238 shares of Supernus Pharmaceuticals worth $199K as of Q3 2019.
Tyers Asset Management bought 264 Supernus Pharmaceuticals shares in Q3 2019, an estimated $7.82K.
Supernus Pharmaceuticals made up 0.01% of Tyers Asset Management's portfolio in Q3 2019, its #715 holding.
Tyers Asset Management first reported a position in Supernus Pharmaceuticals in Q4 2016 and has held it in 12 quarters since.
Tyers Asset Management's Supernus Pharmaceuticals position peaked at $351K in Q3 2018.
243 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.